This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alkermes Pharma Ireland Limited. Active years: 2016-2023.
Location History:
- Royersford, PA (US) (2016)
- Downingtown, PA (US) (2018 - 2023)
Company Filing History:
Years Active: 2016-2023
Title: David M Slifer: Innovator in Nanoparticulate Compositions
Introduction
David M Slifer is a notable inventor based in Downingtown, PA (US). He has made significant contributions to the field of nanoparticulate compositions, holding a total of 6 patents. His work focuses on reducing flake-like aggregation in nanoparticulate active agent compositions, which has important implications in various applications.
Latest Patents
One of his latest patents is titled "Reduction of flake-like aggregation in nanoparticulate active agent compositions." This invention is directed towards minimizing flake-like aggregation in nanoparticulate compositions. The invention encompasses compositions that include a nanoparticulate active agent, at least one surface stabilizer, and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions consist of particles with an effective average particle size of less than about 2000 nm.
Career Highlights
David M Slifer is currently employed at Alkermes Pharma Ireland Limited, where he continues to innovate in the field of pharmaceutical compositions. His expertise in nanoparticulate technology has positioned him as a key player in the industry.
Collaborations
Throughout his career, David has collaborated with notable colleagues, including Peter Snyder and Niels Peter Ryde. These collaborations have further enhanced his research and development efforts in nanoparticulate compositions.
Conclusion
David M Slifer is a distinguished inventor whose work in nanoparticulate compositions has led to significant advancements in the field. His contributions are vital for the development of effective pharmaceutical formulations.